This issue of The Strategist includes:
What impact are GLP-1s having on our bariatric surgery volumes? What about the volumes of other 1 service lines like CV and orthopedics?
How is your system sourcing GLP-1s amidst prolonged national drug shortages?
In addition to weight management medications, what ancillary services are essential for 3 sustained weight loss outcomes?
Do we cover the medications for our own employees? What about for members on our provider- 4 sponsored plans?